Navigation Links
Oral contraceptives safe for women with Lupus erythematosus

Lupus erythematosus (lupus) is a disease in which the body's immune system mistakenly attacks and damages healthy tissues of the skin, joints and internal organs.// A study has found that women who suffer from this disease can take oral contraceptives safely without any complications like increased risk of flares, or periods of increased disease activity, that characterize the disease.

The study was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health (NIH).

The entire study can be described as stated by the researchers as a 15-center study of 183 women with inactive or stable lupus. The women who were taking oral contraceptives (triphasic 35 μg.ethinylestradiol/0.5-1 mg norethindrone for twelve 28-day cycles) had no statistically significant difference in the occurrence of flares than those taking a placebo. Severe flares occurred in about 7 percent of the women, regardless of whether they received oral contraceptives or placebo. A severe flare was defined by several criteria, including the presence of new or worsening central nervous system involvement; inflammation of the blood vessels, kidneys and/or muscles; and/or blood problems, including low platelet count and destruction of the red blood cells.

As put by the authors of the study, "There are settings in which estrogens might provide benefit. Among women with lupus there is a high elective abortion rate – approaching 23 percent of pregnancies – which may reflect a failure of the birth control method used or the absence of an adequate birth control program."

In the words of NIAMS Director Stephen I. Katz, M.D., Ph.D, "Estrogen, as used in this study, appears to be safe in the majority of women with stable disease.This research brings us another step forward in improving quality of life for people with rheumatic disease."

'"/>




Page: 1

Related medicine news :

1. Hormone contraceptives lead to bone problems
2. Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug
3. Lower doses of oral contraceptives helpful in treating acne
4. Dermaseptins: Potent vaginal contraceptives
5. Do oral contraceptives offer protective cover against endometrial cancer?
6. Transdermal HRT not cardioprotective in postmenopausal women with CAD
7. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
8. Starvation in pregnant women can cause heart disease to their children
9. Brisk Walking lowers memory loss in women
10. Young womens woes
11. Young womens woes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2016)... ... May 24, 2016 , ... Mental health watchdog Citizens Commission on ... and renowned professor of psychiatry Thomas Szasz, is continuing its protest against the use ... Death” exhibit in Atlanta, Georgia. The opening of the exhibit follows CCHR’s recent protest ...
(Date:5/24/2016)... , ... May 24, 2016 , ... Loma Linda University ... new adult hospital and expanded Children’s Hospital. Over 3,000 people looked on as the ... Check out the event photo slidehsow. , During the program, Richard H. Hart, ...
(Date:5/24/2016)... ... , ... Backed by decades of experience, Metroloji Okulu works ... best suited solution to meet regulatory requirements. Their professional staff also performs on-site ... , Metroloji Okulu specializes in MadgeTech’s line of medical and pharmaceutical data ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... Growing in ... growing trend, more gluten-free products are available and easily accessible. Whether someone chooses to ... to cater to a certain diet, King Kullen Grocery stocks their shelves with many ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... by 9.3 million people, or 10% over last year, according to data in ... under group policies was comparatively stable, with a slight decrease in risk-based groups ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... York , May 23, 2016 ... report titled, " Exocrine Pancreatic Insufficiency Market - Global ... - 2023 ." According to the report, the exocrine ... CAGR of 8.3% from 2015 to 2023 to reach ... (EPI) is a condition characterized by the deficiency of ...
(Date:5/23/2016)... -- Non-invasive diagnostic test realizes the potential ... to be presented at Yissum’s booth, at IATI-BIOMED 2016 ... of the Hebrew University of Jerusalem announced today ... Ventures MKI, the technology investment arm of Morris Kahn ... for early detection of multiple diseases by analyzing circulating ...
(Date:5/23/2016)... 2016   Purdue Pharma L.P.  today announced ... with Egalet Corporation and Acura Pharmaceuticals, Inc. that ... the agreement the companies will exchange valuable patent ... companies to develop and sell several opioid pain ... reflects the commitment of Purdue Pharma to seek ...
Breaking Medicine Technology: